Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMMP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPM1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GFPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK1IP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADNP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM161B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GKAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FSTL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3C2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYL12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on